Effectiveness and Safety of SGLT2 Inhibitor Treatment on Renal Outcomes in Patients with Type 2 Diabetes: A Nationwide Observational Cohort Study in South Korea

被引：0
|
作者：
Chang, Junhyuk [1 ]
Kim, Chungsoo [1 ]
Choi, Heejung [2 ]
Park, Rae Woong [1 ]
Lee, Sukhyang [3 ]
机构：
[1] Ajou Univ, Dept Biomed Sci, Grad Sch Med, Suwon, South Korea
[2] Ajou Univ, Dept Nephrol, Sch Med, Suwon, South Korea
[3] Ajou Univ, Div Clin Pharm, Coll Pharm, Suwon, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1151
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [21] SGLT2 inhibitor shows promise in type 2 diabetes
    Nature Reviews Drug Discovery, 2010, 9 (3) : 182 - 182
  • [22] Targeting Renal Glucose Reabsorption for the Treatment of Type 2 Diabetes Mellitus Using the SGLT2 Inhibitor Dapagliflozin
    Jabbour, Serge A.
    Whaley, Jean M.
    Tirmenstein, Mark
    Poucher, Simon M.
    Reilly, Timothy P.
    Boulton, David W.
    Saye, JoAnne
    List, James F.
    Parikh, Shamik
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 62 - 73
  • [23] SGLT2 inhibitors in the treatment of type 2 diabetes
    Hasan, Farhad M.
    Alsahli, Mazen
    Gerich, John E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (03) : 297 - 322
  • [24] Long-term Efficacy and Safety of Luseogliflozin, an SGLT2 inhibitor, in Elderly Patients with Type 2 Diabetes
    Sasaki, Takashi
    Seino, Yutaka
    Haneda, Masakazu
    Inagaki, Nobuya
    Fukatsu, Atsushi
    Ubukata, Michito
    Sakai, Soichi
    Samukawa, Yoshishige
    DIABETES, 2014, 63 : A275 - A275
  • [25] Association Between SGLT2 Inhibitor Use and Change in Hemoglobin Among Adults with Diabetes: A Nationwide Cohort Study
    Lassen, Mats C. Hojbjerg
    Colacci, Michael
    Pareek, Manan
    Lee, Stephanie G.
    Gislason, Gunnar
    Fralick, Michael
    Biering-Sorensen, Tor
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (10) : 1945 - 1947
  • [26] Empagliflozin, an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus: A Review of the Evidence
    White, John R., Jr.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (05) : 582 - 598
  • [27] Hereditary renal glycosuria, diabetes and responses to SGLT2 inhibitor
    Ren, Qian
    Gong, Siqian
    Han, Xuyao
    Ji, Linong
    JOURNAL OF DIABETES, 2022, 14 (03) : 216 - 220
  • [28] Hereditary Renal Glycosuria, Diabetes, and Responses to SGLT2 Inhibitor
    Ren, Qian
    Gong, Siqian
    Han, Xueyao
    Ji, Linong
    DIABETES, 2021, 70
  • [29] The Clinical Efficacy and Safety of SGLT2 Inhibitors in Japanese Patients with Type 2 Diabetes
    Tosaki, Takahiro
    Kamiya, Hideki
    Kato, Yoshiro
    Kondo, Masaki
    Nakamura, Jiro
    DIABETES, 2015, 64 : A154 - A155
  • [30] Bexagliflozin (Brenzavvy) - A Fifth SGLT2 Inhibitor for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1683): : 130 - 132
12345